Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial

Victoria K. Snowdon, Neil J. Lachlan, Anna M. Hoy, Patrick W. F. Hadoke, Scott I. Semple, Dilip Patel, Will Mungall, Timothy J. Kendall, Adrian Thomson, Ross J. Lennen, Maurits A. Jansen, Carmel M. Moran, Antonella Pellicoro, Prakash Ramachandran, Isaac Shaw, Rebecca L. Aucott, Thomas Severin, Rajnish Saini, Judy Pak, Denise YatesNeelesh Dongre, Jeremy S. Duffield, David J. Webb, John P. Iredale, Peter C. Hayes, Jonathan A. Fallowfield, Maarten W. Taal (Editor)

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science